Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.

Collin M. Labak(Illinois College), Kiran Kumar Velpula(Illinois College), Paul Y. Wang(Illinois College), Maheedhara R. Guda(Illinois College), Rishab Arora(Illinois College), Andrew J. Tsung(Illinois College), Swapna Asuthkar(University of Illinois Urbana-Champaign)
PubMed
January 1, 2016
Cited by 98

Related Papers

B7-H3 role in the immune landscape of cancer.
|PubMed|2017|175
An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
|PubMed|2018|106
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
|PeerJ|2020|90
Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept
|CNS Oncology|2016|81
Immunopathology of galectin-3: an increasingly promising target in COVID-19
|F1000Research|2020|77